USD 1.35
(4.65%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 42.25 Million USD | -10.79% |
2022 | 47.36 Million USD | 10.05% |
2021 | 43.03 Million USD | 18.26% |
2020 | 36.39 Million USD | 21.02% |
2019 | 30.07 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 8.72 Million USD | -3.6% |
2024 Q1 | 9.04 Million USD | -7.15% |
2023 Q1 | 11.24 Million USD | -7.13% |
2023 FY | 42.25 Million USD | -10.79% |
2023 Q3 | 10.58 Million USD | -0.86% |
2023 Q2 | 10.67 Million USD | -5.1% |
2023 Q4 | 9.74 Million USD | -7.92% |
2022 Q1 | 11.42 Million USD | -5.44% |
2022 Q4 | 12.11 Million USD | 2.81% |
2022 Q3 | 11.78 Million USD | -2.23% |
2022 FY | 47.36 Million USD | 10.05% |
2022 Q2 | 12.05 Million USD | 5.52% |
2021 FY | 43.03 Million USD | 18.26% |
2021 Q4 | 12.07 Million USD | 10.84% |
2021 Q3 | 10.89 Million USD | 2.91% |
2021 Q2 | 10.58 Million USD | 11.75% |
2021 Q1 | 9.47 Million USD | 1.99% |
2020 Q4 | 9.29 Million USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 FY | 36.39 Million USD | 21.02% |
2019 Q3 | - USD | 0.0% |
2019 FY | 30.07 Million USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
CannBioRx Life Sciences Corp. | - USD | -Infinity% |
BIMI International Medical Inc. | 11.83 Million USD | -257.148% |
China Jo-Jo Drugstores, Inc. | 154.54 Million USD | 72.66% |
Harrow Health, Inc. 8.625% Senior Notes due 2026 | 130.19 Million USD | 67.547% |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | 130.19 Million USD | 67.547% |
Leafly Holdings, Inc. | 42.25 Million USD | 0.0% |
LifeMD, Inc. | 152.54 Million USD | 72.302% |
LifeMD, Inc. | 152.54 Million USD | 72.302% |
TRxADE HEALTH, Inc. | 8.27 Million USD | -410.77% |
PetMed Express, Inc. | 281.06 Million USD | 84.967% |
Walgreens Boots Alliance, Inc. | 147.65 Billion USD | 99.971% |